Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes
about
The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites.Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans.5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agents.Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo.Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.Invasion of hepatocytes by Plasmodium sporozoites requires cGMP-dependent protein kinase and calcium dependent protein kinase 4.Directed nucleophilic addition of phenoxides to cyclopropenes.Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies.Plasmodial Kinase Inhibitors: License to Cure?Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum
P2860
Q35187684-F16F4E2C-11A6-458E-93C0-77FF32CE609AQ35592514-B8689372-B0EF-4586-963D-4EFB94F7CAC7Q37401607-AD921634-1AE0-4CBD-BC86-BCF1DDEFCFEAQ37481769-C302B286-BB96-45AE-BF74-5C14D347859FQ38443813-9E3263F2-8A3A-43BA-A687-1C8AFD6CD183Q38736811-412A0C5B-54DE-4989-B267-B584956527D3Q38908654-7786F971-ACC0-4153-A654-FDEB3E7794EEQ39075089-C53B24F3-C366-4A22-B296-5C10F6257F8EQ40421224-03F573E0-3D39-4FD9-9205-40FF25D06C8DQ40610678-1063E12F-2D00-4AD7-AF78-9D2AA7272673Q48334339-DDD97DF3-FF9A-4FFF-AC2F-AEFD6ACAB792Q48336339-6707D6E3-A998-4EBA-B724-2032FEC39181Q48350406-697B6C4B-9C33-42C2-A9A2-8794F5083D75Q54978870-2A0152B0-0D1B-4DFA-B1CA-E7999A91D358Q56347674-1496EFD0-B526-4280-8D1D-C42BFDD55D98
P2860
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of potent and sele ...... ssion of malaria to mosquitoes
@ast
Development of potent and sele ...... ssion of malaria to mosquitoes
@en
Development of potent and sele ...... ssion of malaria to mosquitoes
@nl
type
label
Development of potent and sele ...... ssion of malaria to mosquitoes
@ast
Development of potent and sele ...... ssion of malaria to mosquitoes
@en
Development of potent and sele ...... ssion of malaria to mosquitoes
@nl
prefLabel
Development of potent and sele ...... ssion of malaria to mosquitoes
@ast
Development of potent and sele ...... ssion of malaria to mosquitoes
@en
Development of potent and sele ...... ssion of malaria to mosquitoes
@nl
P2093
P2860
P921
P1476
Development of potent and sele ...... ssion of malaria to mosquitoes
@en
P2093
Anna M W Fox
Arinjay Mitra
Christophe L M J Verlinde
Dustin J Maly
Erkang Fan
Ethan A Merritt
Jen C C Hume
Katelyn R Keyloun
Kayode K Ojo
Mark Kennedy
P2860
P304
P356
10.1016/J.EJMECH.2013.12.048
P577
2014-03-03T00:00:00Z